These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19191749)

  • 1. A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.
    Kohn B; Grasberger H; Lam LL; Ferrara AM; Refetoff S
    Thyroid; 2009 Feb; 19(2):187-91. PubMed ID: 19191749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
    Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.
    Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN
    J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
    Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new silent germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation.
    Gozu HI; Mueller S; Bircan R; Krohn K; Ekinci G; Yavuzer D; Sargin H; Sargin M; Ones T; Gezen C; Orbay E; Cirakoglu B; Paschke R
    Thyroid; 2008 May; 18(5):499-508. PubMed ID: 18466076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.
    Roberts SA; Moon JE; Dauber A; Smith JR
    J Pediatr Endocrinol Metab; 2017 Mar; 30(3):343-347. PubMed ID: 28195550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
    Bertalan R; Sallai A; Sólyom J; Lotz G; Szabó I; Kovács B; Szabó E; Patócs A; Rácz K
    Thyroid; 2010 Mar; 20(3):327-32. PubMed ID: 20146656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
    Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
    J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
    Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
    Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent neonatal thyrotoxicosis in a neonate secondary to a rare thyroid-stimulating hormone receptor activating mutation: case report and literature review.
    Watkins MG; Dejkhamron P; Huo J; Vazquez DM; Menon RK
    Endocr Pract; 2008; 14(4):479-83. PubMed ID: 18558604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R).
    Pohlenz J; Pfarr N; Krüger S; Hesse V
    Acta Paediatr; 2006 Dec; 95(12):1685-7. PubMed ID: 17129985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
    Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
    Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
    Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
    Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
    Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
    Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.
    Tonacchera M; Agretti P; Rosellini V; Ceccarini G; Perri A; Zampolli M; Longhi R; Larizza D; Pinchera A; Vitti P; Chiovato L
    Thyroid; 2000 Oct; 10(10):859-63. PubMed ID: 11081252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
    Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
    J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism.
    Liu Z; Sun Y; Dong Q; He M; Cheng CHK; Fan F
    J Hum Genet; 2008; 53(5):475-478. PubMed ID: 18306976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.
    Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B
    Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
    Polak M
    Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.